Hospitals Management Press Releases | Healthcare Industry Press Releases

New Zealand Research Finds Head-and-Neck Cooling with Cryohelmet™ Significantly Reduces Clinical Symptom Severity After Sports-Related Concussion Injuries

9 October 2019

SHIRLEY, Mass., Oct. 9, 2019 /PRNewswire/ -- All-Star Sporting Goods, makers of the Catalyst Cryohelmet™ (https://www.cryohelmet.com/home) recently

CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million

9 October 2019

HONG KONG and NANJING, China, Oct. 9, 2019 /PRNewswire/ -- Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical Co.,

CNS Summit 2019 Announces Full Agenda for the Most Impactful Event of the Year

9 October 2019

BOCA RATON, Fla., Oct. 9, 2019 /PRNewswire/ -- The CNS Summit, a community passionate about shaping the future of the life sciences with a focus on collaboration, innovation and technology, today announced the agenda for their 10th anniversary Summit. The agenda is now available online and features the top leaders from the FDA, pharmaceutical and biotech companies, techn

Newk\'s Eatery Celebrates Raising More Than $1.4 Million For Ovarian Cancer Research

9 October 2019

JACKSON, Miss., Oct. 9, 2019 /PRNewswire/ -- Newk's Cares, the ovarian cancer awareness movement founded by fast-casual restaurant

Hello Products Gives Teeth and Tastebuds a High-Five with its New Hemp Seed Oil Collection

9 October 2019

MONTCLAIR, N.J., Oct. 9, 2019 /PRNewswire/ -- Hello Products, one of the fastest growing oral care brands in the US, is excited to expand its naturally f

A Pancreatic and Colorectal Cancer Trial Initiated to Address the Needs of Patients With Immune Checkpoint Inhibitor (ICI)-Resistant Disease by Combining Debiopharm\'s Debio 1143 IAP Antagonist With Keytruda®

9 October 2019

LAUSANNE, Switzerland, Oct. 9, 2019 /PRNewswire/ -- Debiopharm (www.debiopharm.com) announced today the first patient enrolment in a Phase I study initiated by Dr. Phillippe Cassier, combining the oral, IAP (Inhibitor of Apoptosis Proteins) antagonist, D

NuVasive to Participate as Gold Sponsor at the EUROSPINE 2019 Annual Meeting

9 October 2019

SAN DIEGO, Oct. 9, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold sponsor at the EUROSPINE 2019 Annual Meeting held October 16-18, 2019 in

Mesothelioma Compensation Center Now Urges Public Utility/Waterworks Worker with Mesothelioma Nationwide to Call Them for Direct Access to Attorney Erik Karst of Karst von Oiste-Get the Compensation You Deserve

9 October 2019

NEW YORK, Oct. 9, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We are the top ranked source in the nation for public utility or water worker

BioMarin to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, October 23 at 4:30pm ET

9 October 2019

SAN RAFAEL, Calif., Oct. 9, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, October 23, at 4:30 p.m. ET to discuss third quarter 2019 financi

A New Cancer Book Offers the Latest Treatment Recommendations

9 October 2019

PANAMA CITY, Fla., Oct. 9, 2019 /PRNewswire/ -- A new edition of the Fundamentals of Radiation Oncology 3rd edition, from Elsevier is now available. Edited by Dr. Hasan Murshed a board certified Radiation Oncologist and Medical Director of Hope Regional Cancer Center in Panama City, FL.